Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 18, 2014

Primary Completion Date

July 20, 2017

Study Completion Date

July 20, 2017

Conditions
PAH
Interventions
DRUG

oral treprostinil

Trial Locations (9)

19104

The Children's Hospital of Philadelphia, Philadelphia

37232

Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

53226

Children's Hospital of Wisconsin, Milwaukee

80045

Children's Hospital Colorado, Aurora

94143

University of California San Francisco, San Francisco

94304

Lucile Packard Children's Hospital, Palo Alto

98105

Seattle Children's Hospital, Seattle

02115

Boston Children's Hospital, Boston

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY